cro quality benchmarking – phase iv service providers (2014)
DESCRIPTION
In its 6th year, ISR’s “CRO Quality Benchmarking – Phase IV Service Providers (2014)” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied satisfaction ratings from 224 service encounters across 24 Phase IV CROs, making this report the most comprehensive assessment of Phase IV CRO service quality in the industry. See more: http://www.isrreports.com/product/cro-quality-benchmarking-phase-iv-service-providers-2014/TRANSCRIPT
QUALITYCRO
BENCHMARKING
PHASE IV
CRO Quality Benchmarking – Phase IV Service Providers (2014)
©2014 Industry Standard Research www.ISRreports.com
PREVIEW
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 2
act with confidence
Report Overview
In its 6th year, ISR’s “CRO Quality Benchmarking – Phase IV Service Providers (2014)” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied satisfaction ratings from 224 service encounters across 24 Phase IV CROs, making this report the most comprehensive assessment of Phase IV CRO service quality in the industry.
228Charts and Graphs
103Respondents
136Pages
224Service Encounters 1. Outsourcing Behaviors, Attitudes, Beliefs, and Intentions
• Phase IV Leaders• Proposal Volume• Service Provider Usage• Service Provider Preference• Service Provider Cost Perceptions
2. Service Provider Selection Drivers• Most Important Service Provider Attributes• Service Provider Attributes Gaining Importance
3. Service Provider Performance and Scorecards Across Attributes• Staff Characteristics Ratings• Operational Excellence Ratings• Organizational and Finance Ratings• Performance Summary by Category• Service Provider Loyalty
4. Service Provider Service Quality Profiles
5. All Study Data
How you can use this report:Study Sponsors• Make a more informed purchase of Phase
IV services by understanding which service providers best fit your company’s needs
• Broaden your Phase IV CRO evaluation list by accessing peer-based service quality ratings across 25 critical attributes
• Pinpoint potential delivery concerns early in a CRO relationship/ evaluation in order to develop proactive strategies to address potential gaps
Phase IV Service Providers• Uncover your own — and competitor —
delivery strengths and weaknesses• Design messaging to tout your company’s
strengths• Compete more effectively by understanding
buyers’ selection criteria and outsourcing trends
NEXT: Companies Included
Report Structure:
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 3
act with confidence
Service Quality Metrics• Commercial market
knowledge
• CRA quality
• Project manager quality
• Project team chemistry
• Responsiveness
• Staff turnover
• Therapeutic expertise
• Timely project communications
• Data quality
• Local market / Regulatory knowledge
• Meeting database lock timelines
• Meeting first patient / first visit timelines
• Meeting overall project timelines
• Network of sites / investigators
• Offered innovative solutions
• Patient recruitment strategy
• Speed of site / investigator recruitment
• Speed of site start-up
• Technology for real-time access to data
• Up-front contingency planning, risk management
• Breadth of services
• Financial strength / stability
• Global footprint
• Low cost
• Minimizing change orders
CROs Included in this Report• Accenture• Bioclinica• Biomedical Systems• Chiltern• Clinipace• Cognizant• Covance• DCRI - Duke
• Eurofins• ICON• INC Research• inVentiv Health Clinical• Mapi• PAREXEL• PPD• PRA
• Premier Research• Quintiles• Radiant• SGS Life Sciences• Tata• Theorem• UBC• Worldwide Clinical Trials
6% C-level
8% President/ VP
52% Director
31% Manager
3% Other
Participant Job Title Participant Geography Participant Company Size
67% Large Companies (R&D $1B or more)
24% Mid-Size Companies (R&D $100M-$999M)
9% Small Companies (R&D less than $100M)
53% North America
12% Asia / Other
35% Europe
Report Metrics
Respondent Demographics (N=103)
Participant Experience: Mean = 14.7 years
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 4
act with confidence
Table of Contents
For full table of contents and additional sample pages, download the full pre-view, free on our website: http://www.isrreports.com/product/cro-quality-benchmarking-phase-iv-service-providers-2014/
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 5
act with confidence
act with confidence
Introduction
www.ISRreports.com ©2014 | CRO Quality Benchmarking — Phase IV Service Providers (2014) 6
Introduction
Welcome to ISR’s 2014 CRO Quality Benchmarking - Phase IV Service Providers report� This report marks the sixth edition of this study and, though the study design is revisited and refreshed each year to account for evolution within the industry, the impetus for performing this research remains the same� Over time, Industry Standard Research has accumulated a wealth of knowledge around service quality and CRO performance� Understanding and utilizing this information allows stakeholders within the industry to make informed decisions when choosing a CRO for Phase IV services�
ISR knows that selecting a CRO isn’t easy� There is a myriad of factors to evaluate for each CRO being considered� Does the provider have the necessary therapeutic expertise? Will the trial be completed on time and within budget? Does the provider have sufficient knowledge about local markets and regulatory environments? Without prior experience with a provider, purchasers of CRO services are often forced to rely on incomplete or biased assessments of CRO performance passed on through word of mouth from peers within the industry�
In the CRO Quality Benchmarking - Phase IV report, ISR provides the data necessary to answer these questions – and many more – with confidence� 103 decision-makers have weighed in with their CRO selection criteria and outsourcing behaviors� They have provided feedback on 224 recent service encounters across 24 Phase IV CROs� Nine providers have received detailed profiles�
Not only does this report enable more educated purchases of CRO services, it also allows Phase IV service providers to get a behind-the-scenes look at customers’ perceptions of their performance� Providers can determine areas of strength and understand where they may need to close the gap relative to competitors� As they say, knowledge is power� Having a grasp on customer beliefs, attitudes, and experiences will help CROs effectively promote their strengths and improve areas in which they are falling short�
Sample Page
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 6
act with confidence
act with confidence
Service Provider Performance and Scorecards Across Attributes
www.ISRreports.com ©2014 | CRO Quality Benchmarking Phase I Service Providers (2014) 27
Figure 2 – “Operational Excellence” Ratings
Performance in Operational Excellence shows more variability among Phase I providers� The non-large, multi-service providers Quotient Clinical and SGS Life Sciences stand out for going beyond expectations as well as Phase I focused provider Clinical Research Services (CRS)� Respondents also rate PPD as more frequently exceeding expectations in Operational Excellence compared to other large, multi-service providers�
Technology for real-time
access to data
Speed of site
start-upData
Quality
Local market /
regulatory knowledge
Meeting Overall Project
Timelines
Meeting Database
Lock Timelines
Meeting First Patient / First Visit Timelines
O�ers Innovative Solutions
Patient / Volunteer
Recruitment
Up-front contingency planning, risk management
Timely project communications
Covance
ICON
INC Research
inVentiv Health Clinical
PAREXEL
PPD
PRA
Quintiles
Charles River
Medpace
Premier Research
Quotient Clinical
SGS Life Sciences
US Oncology
Celerion
Clinical Research Services (CRS)
WCCT Global
Operational Excellence
LARGE MULTI-SERVICE CROS
NON-LARGE MULTI-SERVICE CROS
PRIMARILY PHASE I FOCUSED CROS
Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deficiency
© Industry Standard Research
Sample Page
Figure 1 – Staff Characteristics Ratings
Company A
Company B
Company C
Company D
Company E
Company F
Company G
Company H
Company I
Staff turnover
CRA quality
Project team
chemistry
Project manager quality Responsiveness
Therapeutic expertise
Timely project communications
Commercial market
knowledge
Sta Characteristics
Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deficiency
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 7
act with confidence
Sample PageSample Page
For full table of contents and additional sample pages, download the full pre-view, free on our website: http://www.isrreports.com/product/cro-quality-benchmarking-phase-iv-service-providers-2014/
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 8
act with confidence
Ordering Information
Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise. For more information about our off-the-shelf intelligence and custom research offerings, please visit our Web site at www.ISRreports.com, email [email protected], or follow us on twitter @ISRreports.
About Industry Standard Research
Save on this, or any ISR report, by
registering a free account
Register now• Receive a $250 instant credit towards any ISR report• Earn 10% credit towards all future purchases• Receive advanced notifications on ISR’s latest reports and free resources
For pricing and ordering information, visit our website: http://www.isrreports.com/product/cro-quality-benchmarking-phase-iv-service-providers-2014/
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 9
act with confidence
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 9
act with confidence
www.ISRreports.com ©2014 | Preview of: Benchmarking European Investigator Payments 10
act with confidence
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10
act with confidence
The ISR DifferenceCustom-quality syndicated market research
www.ISRreports.com
ISR's Reports The Common Syndicated Reportvs.
How confident are you?
vs.Data Collection
ISR's proprietary data collection tools and channels support fast,
high quality data collection
Struggle to recruit the right targets and enough of them
vs.Sample Sizes
Robust sample sizes that instill confidence
Often insufficient industry representation that leaves you
defending results
vs.vs.Research methods
Mostly primary research;
always appropriate for the topic
One size fits all; usually publically
available data
vs.vs.Respondents
Sophisticated screening ensures genuine decision-makers
Undisclosed methodologies and
respondent demographics
vs.vs.Analysts
Decades of experience means more insights that are
immediately usable
Junior analysts capable of reporting numbers